BRISTOL DROXIA DECREASES MEDIAN ANNUAL SICKLE CELL CRISES BY 46%, TRANSFUSIONS BY 37%; LABELING WILL STRESS BI-WEEKLY BLOOD MONITORING FOR NEUTROPENIA